Search Results - "Ristović, Z."

Salivary immunoglobulins in cancer patients with chemotherapy-related oral mucosa damage by JANKOVIC, L, JELIC, S, FILIPOVIC-LJESKOVIC, I, RISTOVIC, Z

“…In 40 patients with neoplastic disorders treated with chemotherapy containing anthracyclines or 5-fluorouracil, objective changes of the oral mucosa were…”
Get full text

Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma by JELIC, S, KOVCIN, V, MILANOVIC, N, BABOVIC, N, KREACIC, M, RISTOVIC, Z, VLAJIC, M, FILIPOVIC-LJESKOVIC, I

“…A randomised study was started in chemotherapy-naive patients with advanced soft tissue sarcomas who received either epirubicin 60 mg/m 2/24 h (total dose for…”
Get full text

Randomized study of zorubicin versus zorubicin-cisplatin in undifferentiated carcinoma of the nasopharynx (UCNT) by Jelić, S., Kovčin, V., Milanović, N., Kreačić, M., Pendjer, I., Jovanović, V., Ristović, Z., Oprić, M., Mitrović, L.

“…Background The most active chemotherapy regimens in UCNT were those combining anthracyclines (doxorubicin or epirubicin) and cisplatin. Our previous pilot…”
Get full text

Cardioprotection with ICRF-187 (Cardioxane) in patients with advanced breast cancer having cardiac risk factors for doxorubicin cardiotoxicity, treated with the FDC regimen by Jelić, S, Radulović, S, Nesković-Konstantinović, Z, Kreacić, M, Ristović, Z, Bosnjak, S, Milanović, N, Vuletić, L

“…A study of cardioprotection with ICRF-187 (Cardioxane, Eurocetus) has been performed in 35 patients with metastatic breast cancer treated with the FDC regimen…”
Get full text

1104 (Lack of) correlation between carboplatin (CBDCA) dose and treatment outcome in squamous cell bronchogenic carcinoma (NSCLC) by Radulović, S., Jelić, S., Ristović, Z., Kocić, D.

“…In a prospective study 160 untreated patients with clinical stage IIIb and IV NSCLC were randomized to receive vindesin-mitomycin C-cisplatin or…”
Get full text

1068 Cisplatin 120mg/m2 vs. carboplatin 500mg/m2 in combination with mitomycin c and vindesin; a randomized phase III study in 164 patients with stage IIIB and IV squamous-cell bronhogenic carcinoma by Jelić, S., Mitrović, L., Radosavljević, D., Elezar, E., Kovćin, V., Ristović, Z., Kovacević, S., Radulović, S.

Get full text

224 Comparison of efficacy two different dose DTIC-based chemotherapy regimens and two non-DTIC based regimens in the treatment of metastatic malignant melanoma; study in 159 patients by Kovčin, V., Jelić, S., Mitrović, L., Radulović, S., Tomašević, Z., Milanovtć, N., Babović, N., Ristović, Z.

“…159 patients with disseminated malignant melanoma entered the four arm randomized study. Arm A: Adriamycin ADM 40 mg/m 2 day 1, BCNU 120 mg/m 2 and Vincristin…”
Get full text

1068 Cisplatin 120 mg/m 2 vs. carboplatin 500 mg/m 2 in combination with mitomycin c and vindesin; a randomized phase III study in 164 patients with stage IIIB and IV squamous-cell bronhogenic carcinoma by Jelić, S., Mitrović, L., Radosavljević, D., Elezar, E., Kovćin, V., Ristović, Z., Kovacević, S., Radulović, S.

“…A randomized phase III study of Cisplatin vs. Carboplatin in 1:4 ration in patients with stage IIIb and IV squamous cell bronhogenic carcinoma, in combination…”
Get full text

Antinociceptive Activity of the Novel Fentanyl Analogue iso-Carfentanil in Rats by Vučković, Sonja, Prostran, Milica, Ivanović, Milovan, Ristović, Zorana, Stojanović, Radan

“…A large number of fentanyl analogues have been synthesized so far, both to establish the structure-activity-relationship (SAR) and to find novel, clinically…”
Get full text

Treatment of tumour-induced hypercalcaemia in advanced breast cancer patients with three different doses of disodium pamidronate adapted to the initial level of calcaemia by Nesković-Konstantinović, Z, Mitrović, L, Petrović, J, Stamatović, L, Ristović, Z

“…A group of 38 female patients with advanced breast cancer experiencing the first occurrence of tumour-induced hypercalcaemia (TIH), mostly with osteolytic…”
Get full text

Higher Environmental Temperature Potentiates Cataleptic Effect of Fentanyl in Rats by Sonja, Vučković, Milovan, Ivanović, Milica, Prostran, Zoran, Todorović, Zorana, Ristović, Ivan, Mićović, Dušan, Beleslin

“…The influence of higher environmental temperature (HET = 30±1°C) on fentanyl-induced behavior was studied in unrestrained rats. Subacute exposure (3 days) of…”
Get full text

45 Survival advantage for carboplatin 500 mg/mg2 substituting cisplatin 120 mg/m2 in combination with vindesine and mitomycin C in patients with stage IIIB and IV squamous-cell bronchogenic carcinoma: A randomized phase III study in 221 patients by Jelić, S., Radosavjelić, D., Elezar, E., Radulović, S., Ristović-Bizetić, Z.

Get full text

45 Survival advantage for carboplatin 500 mg/mg 2 substituting cisplatin 120 mg/m 2 in combination with vindesine and mitomycin C in patients with stage IIIB and IV squamous-cell bronchogenic carcinoma: A randomized phase III study in 221 patients by Jelić, S., Radosavjelić, D., Elezar, E., Radulović, S., Ristović-Bizetić, Z.

Get full text

893 Advantages of the computer program “HEM” in following, processing and analizing data of chemotherapy trials by Ristoviċ, Z., Jeliċ, S., Kovčir, V., Vučković, S., Ribanć, B., Vulenċ-Mitroviċ, L.

“…One of the most difficult stages in clinical drug trials is collecting, selecting and analyzing data. In the past, this was done manually, which took almost…”
Get full text